ANDA 061897

LILLY

FDA Drug Application

Application #061897

Application Sponsors

ANDA 061897

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	CAPSULE;ORAL	EQ 125MG BASE	0	ILOSONE	ERYTHROMYCIN ESTOLATE
002	CAPSULE;ORAL	EQ 250MG BASE	0	ILOSONE	ERYTHROMYCIN ESTOLATE

FDA Submissions

	ORIG	1	AP	1975-01-06
MANUF (CMC); Manufacturing (CMC)	SUPPL	10	AP	1990-04-10
MANUF (CMC); Manufacturing (CMC)	SUPPL	12	AP	1990-04-10
LABELING; Labeling	SUPPL	13	AP	1991-10-23
LABELING; Labeling	SUPPL	14	AP	1991-09-05
LABELING; Labeling	SUPPL	15	AP	1991-01-14
MANUF (CMC); Manufacturing (CMC)	SUPPL	16	AP	1992-01-27
LABELING; Labeling	SUPPL	22	AP	1997-07-22

Submissions Property Types

ORIG	1	Null	0
SUPPL	10	Null	0
SUPPL	12	Null	0
SUPPL	13	Null	0
SUPPL	14	Null	0
SUPPL	15	Null	0
SUPPL	16	Null	0
SUPPL	22	Null	0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61897
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)